ニューヨークにおける非筋層浸潤性膀胱癌の臨床試験
ニューヨーク内の拠点で、非筋層浸潤性膀胱癌に関する16件の研究が参加者を募集しています。
ニューヨーク内の都市
- New York City10件の研究
- Syracuse8件の研究
- Queens4件の研究
- Staten Island4件の研究
- Greenburgh4件の研究
- New Rochelle3件の研究
- Buffalo3件の研究
- The Bronx3件の研究
公式研究テキスト（英語）
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medical Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06503614Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai (ISMMS) - Mount Sinai Queens - Infusion Center, Astoria
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Associated Medical Professionals, Syracuse
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- MSK Commack, Commack
- MSK Westchester, Harrison
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- 他9件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- SUNY Upstate Med Univ, Syracuse
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- Roswell Park Comprehensive Cancer Center, Buffalo
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06733363Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
- University of Rochester, Department of Urology, Rochester
- Associated Medical Professionals of NY, PLLC, Syracuse
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- 他4件
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
- Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), East White Plains
- Columbia University (Data Collection Only), New York
- 他2件
被験者募集中第3相
21歳以上 · 全性別 · 2026/08/20更新 · NCT06929286Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/14更新 · NCT05126472LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Albany Medical College, Albany
- Roswell Park Cancer Institute, Buffalo
- Mount Sinai Medical Center, New Haven
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- SUNY Upstate Medical University, Syracuse
被験者募集中第1/2相
18歳〜85歳 · 全性別 · 2026/03/27更新 · NCT06800963Blue Light Cystoscopy With Cysview® Registry
- NYU Langone's Perlmutter Cancer Center, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-015 - Associated Medical Professionals of New York, Syracuse
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/24更新 · NCT03945162ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。